Ciprofloxacin versus cefuroxime axetil in the treatment of adult patients with acute bacterial sinusitis

Journal of Otolaryngology

Volumn 27, Issue 1, 1998, Pages 10-16

  Klein, Gerald L ^a   Whalen, Edward ^a   Echols, Roger M ^a   Heyd, Allen ^a  

^a NONE

Author keywords

Acute bacterial sinusitis; Cefuroxime axetil; Ciprofloxacin; Drug comparison

Indexed keywords

ANTIBIOTIC AGENT; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACUTE DISEASE; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SINUSITIS; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; AGED; ANALYSIS OF VARIANCE; ANTI-INFECTIVE AGENTS; CEFUROXIME; CEPHALOSPORINS; CHI-SQUARE DISTRIBUTION; CIPROFLOXACIN; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; RANDOM ALLOCATION; SINUSITIS;

EID: 0031913934     PISSN: 03816605     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Vital and Health Statistics. National Ambulatory Medical Care Survey; U.S. Department of Health and Human Services, Maryland, 1994. DHHS Publication Number (PHS) 94-1777.
2. Wald ER. Epidemiology, pathophysiology and etiology of sinusitis. Pediatr Infect Dis 1985; 4:51-53.
3. Gwaltney JM. Acute community-acquired sinusitis. Clin Infect Dis 1996; 23:1209-1225.
4. Gwaltney JM Jr, Scheld WM, Sande MA, Syndor A Jr. The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: a fifteen-year experience at the University of Virginia and review of other selected studies. J Allergy Clin Immunol 1992; 90:457-462.
5. Goodman GM, Slaven RG. Medical management in adults of chronic sinus disease. Immunol Allergy Clin North Am 1994; 14:69-87.
6. Slavin RG. Sinusitis in adults and its relation to allergic rhinitis, asthma, and nasal polyps. J Allergy Clin Immunol 1988; 82:950-956.
7. Falser N, Mittermayer H, Wade H. Antibacterial treatment of otitis and sinusitis with ciprofloxacin and penicillin V - a comparison. Infection 1988; 16(Suppl 1):S51-S54.
8. Saito H, Ohbori Y, Furuta S, et al. Laboratory and clinical studies on Bay o 9867 (ciprofloxacin) in otolaryngological field (Japan). Chemotherapy 1985; 33(Suppl 7):995-1009.
9. Mori Y, Baba S, Kinoshita H, et al. Laboratory and clinical studies on Bay o 9867 in otorhinolaryngological field (Japan). Chemotherapy 1985; 33(Suppl 7):978-987.
10. Fujimaki Y, Kawamura S, Watanabe H, et al. Fundamental and clinical studies on Bay o 9867 (ciprofloxacin) in otorhinolaryngological field (Japan). Chemotherapy 1985; 33(Suppl 7): 970-977.
11. Fombeur JP, Barrault S, Koubbi G, et al. Study of the efficacy and safety of ciprofloxacin in the treatment of chronic sinusitis. Chemotherapy 1994; 40(Suppl 1):24-28.
12. Legent F, Bordure PH, Beauvillain C, Berche P. A double-blind comparison of ciprofloxacin and amoxycillin/clavulanic acid in the treatment of chronic sinusitis. Chemotherapy 1994; 40(Suppl 1):8-15.
13. Barry AL, Pfaller MA, Fuchs PC, Packer RR. In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. medical centers in 1992 and 1993. Antimicrob Agents Chemother 1994; 38:2419-2425.
14. 90 and eradication of nasopharyngeal carriage of bacteria. J Infect Dis 1990; 162:1124-1127.
15. Syndor A, Gwaltney JM, Cocchetto DM, Scheld WM. Comparative evaluation of cefuroxime axetil and cefaclor for the treatment of acute bacterial maxillary sinusitis. Arch Otolaryngol Head Neck Surg 1989; 115:1430-1433.
16. Camacho AE, Cobo R, Otte J, et al. Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with acute bacterial maxillary sinusitis. Am J Med 1992; 93:271-276.
17. Hebblethwaite EM, Brown GW, Cox DM. A comparison of the efficacy and safety of cefuroxime axetil and augmentin in the treatment of upper respiratory tract infection. Drugs Explt Clin Res 1987; 13:91-94.
18. Gehanno P, Boucot I, Chiche D, et al. Treatment of community acquired acute sinusitis: cefuroxime axetil vs cefixime. Medecine et Maladies Infectieuses 1991; 21:61-65.
19. Brodie DP, Knight S, Cunningham K. Comparative study of cefuroxime axetil and amoxicillin in the treatment of acute sinusitis in general practice. J Int Med Res 1989; 17:547-551.
20. Griffiths GK, VandenBurg MJ, Wight LJ, et al. Efficacy and tolerability of cefuroxime axetil in patients with upper respiratory tract infection. Curr Med Res Opin 1987; 10:555-561.
21. Chow AW, Hall CB, Klein JO, et al. Evaluation of new antiinfective drugs for the treatment of respiratory tract infections. Clin Infect Dis 1992; 15(Suppl 1):S62-S88.
22. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests, M2-A5. Villanova, PA: National Committee for Clinical Laboratory Standards, 1993.
23. Heyd A, Echols R, Shan M, et al., and the Sinusitis Study Group. Oral ciprofloxacin vs. cefuroxime axetil in the treatment of acute sinusitis (Abstract LM31). In: Proceedings of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, California, September, 1995.